Piramal Pharma Solutions

Investment to boost capacity for sterile injectable drug manufacturing, create 40 new jobs in Kentucky

The new production area, known as V Block, can handle batch sizes of 150 to 600 kg, augmenting the site’s capacity to produce oral…

The benefits of this new investment will be seen in an improved experience for PPS discovery services customers

This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs

It will expand existing capacities and build new capabilities for the development and manufacturing of APIs

The integrated programme, involving three Piramal Pharma Solutions sites, encompasses formulation development, supply of APIs and…

Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…

Located in Sellersville, Pennsylvania, this facility will broaden the offering of Piramal Pharma Solutions (PPS) by adding solid…

The construction is expected to be completed by April 30, 2021, Piramal Pharma Solutions said in a statement

Expansion enhances the company’s ability to serve the growing ADC market Piramal Pharma Solutions (PPS), a leading Contract…